Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.09% | 6.32% | -13.91% | -7.08% | 15.14% |
| Total Depreciation and Amortization | -19.77% | -27.76% | -35.18% | -29.57% | -25.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.54% | -52.51% | -50.32% | -20.10% | 18.91% |
| Change in Net Operating Assets | 73.06% | 63.05% | 101.02% | 106.26% | 72.64% |
| Cash from Operations | 12.23% | 2.81% | -1.43% | 45.56% | 42.69% |
| Capital Expenditure | 33.82% | 5.29% | -14.68% | 57.43% | 66.16% |
| Sale of Property, Plant, and Equipment | -92.50% | 207.31% | 205.48% | 485.37% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.42% | 41.72% | 439.78% | 442.00% | 170.30% |
| Cash from Investing | -37.85% | 43.59% | 480.39% | 529.43% | 203.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 2,400.00% | -- |
| Issuance of Common Stock | -8.94% | -14.10% | -19.04% | -13.17% | -41.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -118.79% | 25.59% | 8.94% | 57.36% | 42.51% |
| Cash from Financing | -13.74% | -16.57% | -22.04% | -8.59% | -41.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.23% | 59.10% | 97.05% | 128.32% | 109.46% |